FDA Approves Omalizumab to Reduce Food-Based Allergic Reactions in Adult and Pediatric Patients

This marks omalizumab’s fourth FDA-approved indication for allergic and inflammatory conditions, such as severe persistent allergic asthma, with its initial approval being in 2003.

Related Keywords

United States , America , Stepan Popov , Levi Garraway , Kenneth Mendez , Food Allergy Research , Allergy Foundation Of America , Genentech United States , Sung Poblete , Allergy Foundation ,